Suppr超能文献

基于磁共振成像的多发性硬化症和视神经脊髓炎谱系障碍生物标志物:系统评价与荟萃分析。

Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.

作者信息

Mirmosayyeb Omid, Yazdan Panah Mohammad, Moases Ghaffary Elham, Vaheb Saeed, Ghoshouni Hamed, Shaygannejad Vahid, Pinter Nandor K

机构信息

Department of Neurology, Jacobs Comprehensive MS Treatment and Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St., Buffalo, NY, 14203, USA.

Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran.

出版信息

J Neurol. 2024 Dec 16;272(1):77. doi: 10.1007/s00415-024-12827-x.

Abstract

BACKGROUND/OBJECTIVE: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are neuroinflammatory conditions with overlapping clinical and imaging features. Distinguishing between these diseases is crucial for appropriate diagnosis and management. Magnetic resonance imaging (MRI) may have the potential to differentiate these disorders. Nonetheless, studies exhibit inconsistencies regarding which MRI measurements most effectively distinguish between these disorders. Hence, this review aimed to evaluate the differences in MRI volumetry between people with MS (PwMS) and people with NMOSD (PwNMOSD).

METHODS

A systematic search was conducted across PubMed/MEDLINE, Embase, Scopus, and Web of Science up to May 12, 2024, to identify studies assessing conventional and volumetric MRI in PwMS and PwNMOSD. The standard mean difference (SMD) of MRI measurements and its 95% confidence interval (CI) were estimated using R version 4.4.0 with a random-effects model.

RESULTS

Forty-eight original studies that assessed conventional MRI measurements in 2592 PwMS and 1979 PwNMOSD were included. The meta-analysis revealed that PwMS had significantly higher T2 lesion volume (SMD = 1.51, 95% CI: 0.53 to 2.48, p = 0.002) and T1 lesion count (SMD = 1.08, 95% CI: 0.56 to 1.6, p < 0.001) than PwNMOSD. PwMS also exhibited significantly reduced thalamic volume (SMD = -1.26, 95% CI: -1.8 to -0.73, p < 0.001) and grey matter volume (GMV) (SMD = -0.65, 95% CI: -0.92 to -0.37, p < 0.001). Other MRI volumetry, such as the brain and putamen volumes, showed more pronounced atrophy in PwMS.

CONCLUSION

Significant differences in MRI volumetry between MS and NMOSD highlight the potential of MRI as a critical diagnostic tool. These findings emphasize the need for standardized MRI protocols and advanced imaging techniques to enhance diagnostic accuracy and clinical management of these conditions.

摘要

背景/目的:多发性硬化症(MS)和视神经脊髓炎谱系障碍(NMOSD)是具有重叠临床和影像学特征的神经炎症性疾病。区分这些疾病对于正确的诊断和管理至关重要。磁共振成像(MRI)可能有区分这些疾病的潜力。尽管如此,关于哪些MRI测量方法能最有效地区分这些疾病,研究结果并不一致。因此,本综述旨在评估MS患者(PwMS)和NMOSD患者(PwNMOSD)之间MRI容积测量的差异。

方法

截至2024年5月12日,在PubMed/MEDLINE、Embase、Scopus和Web of Science数据库中进行了系统检索,以确定评估PwMS和PwNMOSD患者常规MRI和容积MRI的研究。使用R 4.4.0版本和随机效应模型估计MRI测量的标准平均差(SMD)及其95%置信区间(CI)。

结果

纳入了48项评估2592例PwMS和1979例PwNMOSD患者常规MRI测量的原始研究。荟萃分析显示,PwMS的T2病变体积(SMD = 1.51,95% CI:0.53至2.48,p = 0.002)和T1病变计数(SMD = 1.08,95% CI:0.56至1.6,p < 0.001)显著高于PwNMOSD。PwMS的丘脑体积(SMD = -1.26,95% CI:-1.8至-0.73,p < 0.001)和灰质体积(GMV)(SMD = -0.65,95% CI:-0.92至-0.37,p < 0.001)也显著降低。其他MRI容积测量,如脑体积和壳核体积,在PwMS中显示出更明显的萎缩。

结论

MS和NMOSD之间MRI容积测量的显著差异突出了MRI作为关键诊断工具的潜力。这些发现强调了需要标准化的MRI方案和先进的成像技术,以提高这些疾病的诊断准确性和临床管理水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验